Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionWealthfront Advisers Llc
Latest Disclosed Ownership244,488 shares
Latest Disclosed Value $ 34,074,293
Wealthfront Advisers Llc reports 2.70% increase in ownership of GILD / Gilead Sciences, Inc.

On May 5, 2026 - Wealthfront Advisers Llc filed a 13F-HR form disclosing ownership of 244,488 shares of Gilead Sciences, Inc. (CH:GILD) valued at $34,074,293 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 238,068 shares of Gilead Sciences, Inc.. This represents a change in shares of 2.70% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F GILEAD SCIENCES COM 375558103 244,488 6,420 2.70 34,074 16.61 0.0748
2026-01-30 2025-12-31 13F GILEAD SCIENCES COM 375558103 238,068 2,224 0.94 29,220 11.62 0.0653
2025-11-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 235,844 -13,010 -5.23 26,179 -5.12 0.0615
2025-07-31 2025-06-30 13F GILEAD SCIENCES COM 375558103 248,854 34,942 16.33 27,590 15.11 0.0711
2025-05-02 2025-03-31 13F GILEAD SCIENCES COM 375558103 213,912 47,269 28.37 23,969 55.72 0.0643
2025-04-01 2024-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 166,643 27,673 19.91 15,393 32.11 0.0450
2025-02-07 2024-12-31 13F GILEAD SCIENCES COM 375558103 52,011 -86,959 9,464 0.0286
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 138,970 29,426 26.86 11,651 55.04 0.0358
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 109,544 -57,583 -34.45 7,516 -38.61 0.0253
2024-04-19 2024-03-31 13F GILEAD SCIENCES COM 375558103 167,127 -16,335 -8.90 12,242 -17.63 0.0428
2024-02-09 2023-12-31 13F GILEAD SCIENCES COM 375558103 183,462 672 0.37 14,862 8.50 0.0571
2023-11-01 2023-09-30 13F GILEAD SCIENCES COM 375558103 182,790 -65,612 -26.41 13,698 -28.45 0.0590
2023-08-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 248,402 7,879 3.28 19,144 -4.07 0.0812
2023-04-28 2023-03-31 13F GILEAD SCIENCES COM 375558103 240,523 37,018 18.19 19,956 14.23 0.0907
2023-02-10 2022-12-31 13F GILEAD SCIENCES COM 375558103 203,505 3,373 1.69 17,471 41.50 0.0847
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 200,132 58,994 41.80 12,346 41.52 0.0656
2022-07-20 2022-06-30 13F GILEAD SCIENCES COM 375558103 141,138 55,110 64.06 8,724 70.56 0.0438
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 86,028 -22,947 -21.06 5,115 -35.36 0.0224
2022-01-21 2021-12-31 13F GILEAD SCIENCES COM 375558103 108,975 9,043 9.05 7,913 13.37 0.0335
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 99,932 25,447 34.16 6,980 36.09 0.0323
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 74,485 12,240 19.66 5,129 27.49 0.0244
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 62,245 8,027 14.81 4,023 27.35 0.0215
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 54,218 -8,760 -13.91 3,159 -20.63 0.0190
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 62,978 -24,561 -28.06 3,980 -40.91 0.0284
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 87,539 26,186 42.68 6,735 46.83 0.0522
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 61,353 44,973 274.56 4,587 331.11 0.0417
2020-01-21 2019-12-31 13F GILEAD SCIENCES COM 375558103 16,380 -4,545 -21.72 1,064 -19.76 0.0079
2019-10-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 20,925 -1,998 -8.72 1,326 -14.40 0.0111
2019-08-13 2019-06-30 13F GILEAD SCIENCES COM 375558103 22,923 9,443 70.05 1,549 76.83 0.0135
2019-05-13 2019-03-31 13F GILEAD SCIENCES COM 375558103 13,480 -11,604 -46.26 876 -44.17 0.0081
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 25,084 25,084 1,569 0.0167
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.